Login / Signup

Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.

David Gordon LichterLinda A Hershey
Published in: Neurology (2023)
Keyphrases
  • pet ct
  • parkinson disease
  • clinical trial
  • positron emission tomography
  • pet imaging
  • mild cognitive impairment
  • computed tomography
  • deep brain stimulation
  • cognitive impairment
  • phase ii
  • open label